”The Cancer Research Institute is pleased to announce the addition of two key leaders- Rachael Brown, who joined CRI as Chief Development Officer in mid-September, and Scott G., who assumed the role of Chief Operations Officer in early October.
These strategic appointments underscore our commitment to enhancing our fundraising efforts and operational excellence, as we continue to lead the charge in cancer immunotherapy through our People X Biology X Data – strategic approach.
‘We are thrilled to have Rachael and Scott join our team,’ expresses CRI’s CEO Alicia Zhou.
‘Rachael’s exceptional track record in building strategic partnerships and Scott’s operational expertise will be invaluable as we push forward in our mission to revolutionize cancer treatment. Together, they bring the experience and passion needed to drive CRI’s next phase of growth and impact.’